Cigna Corp (CI): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Cigna ( CI) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Cigna rose $0.87 (1.1%) to $78.59 on heavy volume. Throughout the day, 3,176,264 shares of Cigna exchanged hands as compared to its average daily volume of 1,403,400 shares. The stock ranged in a price between $77.73-$79.49 after having opened the day at $77.84 as compared to the previous trading day's close of $77.72. Other companies within the Health Care sector that increased today were: Retractable Technologies ( RVP), up 71.7%, GW Pharmaceuticals PLC ADR ( GWPH), up 69.3%, Verenium Corporation ( VRNM), up 58.2% and Electromed ( ELMD), up 25.5%.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $23.7 billion and is part of the health services industry. Shares are up 56.6% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Prosensa Holding N.V ( RNA), down 70.2%, ERBA Diagnostics ( ERB), down 17.9%, Imprimis Pharmaceuticals ( IMMY), down 13.5% and Ohr Pharmaceutical ( OHRP), down 12.9% , were all laggards within the health care sector with Actavis ( ACT) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Healthcare Management Stocks Look Too Pricey for Activists

The Stock That Crashed 25% Overnight Has a Lesson to Teach Us: Market Recon